Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

Health technology assessment, value-based decision making, and innovation.

Henshall C, Schuller T; HTAi Policy Forum..

Int J Technol Assess Health Care. 2013 Oct;29(4):353-9. doi: 10.1017/S0266462313000378.

PMID:
23845404
2.

Adaptive approaches to licensing, health technology assessment, and introduction of drugs and devices.

Husereau D, Henshall C, Jivraj J.

Int J Technol Assess Health Care. 2014 Jul;30(3):241-9. doi: 10.1017/S0266462314000191.

PMID:
24921416
3.

Using health technology assessment to support optimal use of technologies in current practice: the challenge of "disinvestment".

Henshall C, Schuller T, Mardhani-Bayne L.

Int J Technol Assess Health Care. 2012 Jul;28(3):203-10. doi: 10.1017/S0266462312000372.

PMID:
22792877
4.

Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.

Chilcott J, Tappenden P, Rawdin A, Johnson M, Kaltenthaler E, Paisley S, Papaioannou D, Shippam A.

Health Technol Assess. 2010 May;14(25):iii-iv, ix-xii, 1-107. doi: 10.3310/hta14250. Review.

5.

Health technology assessment of medical devices: What is different? An overview of three European projects.

Schnell-Inderst P, Mayer J, Lauterberg J, Hunger T, Arvandi M, Conrads-Frank A, Nachtnebel A, Wild C, Siebert U.

Z Evid Fortbild Qual Gesundhwes. 2015;109(4-5):309-18. doi: 10.1016/j.zefq.2015.06.011. Review.

PMID:
26354131
6.

Health technology assessment: principles, methods and current status.

Giovagnoni A, Bartolucci L, Manna A, Morbiducci J, Ascoli G.

Radiol Med. 2009 Aug;114(5):673-91. doi: 10.1007/s11547-009-00387-5. English, Italian.

PMID:
19367465
7.

Prioritizing investments in health technology assessment. Can we assess potential value for money?

Davies L, Drummond M, Papanikolaou P.

Int J Technol Assess Health Care. 2000 Winter;16(1):73-91.

PMID:
10815355
8.

Health technology assessment to optimize health technology utilization: using implementation initiatives and monitoring processes.

Frønsdal KB, Facey K, Klemp M, Norderhaug IN, Mørland B, Røttingen JA.

Int J Technol Assess Health Care. 2010 Jul;26(3):309-16. doi: 10.1017/S0266462310000309. Review.

PMID:
20584360
9.

The impact of health technology assessment reports on decision making in Austria.

Zechmeister I, Schumacher I.

Int J Technol Assess Health Care. 2012 Jan;28(1):77-84. doi: 10.1017/S0266462311000729.

PMID:
22233544
10.

Ethical analysis to improve decision-making on health technologies.

Saarni SI, Hofmann B, Lampe K, Lühmann D, Mäkelä M, Velasco-Garrido M, Autti-Rämö I.

Bull World Health Organ. 2008 Aug;86(8):617-23.

11.

Role of technology assessment in health benefits coverage for medical devices.

Braslow NM, Shatin D, McCarthy DB, Newcomer LN.

Am J Manag Care. 1998 Sep 25;4 Spec No:SP139-50.

12.

Risk management frameworks for human health and environmental risks.

Jardine C, Hrudey S, Shortreed J, Craig L, Krewski D, Furgal C, McColl S.

J Toxicol Environ Health B Crit Rev. 2003 Nov-Dec;6(6):569-720. Review.

PMID:
14698953
13.

[Quality of health care, accreditation, and health technology assessment in Croatia: role of agency for quality and accreditation in health].

Mittermayer R, Huić M, Mestrović J.

Acta Med Croatica. 2010 Dec;64(5):425-34. Croatian.

PMID:
21692267
14.

Role of health technology assessment in shaping the benefits package in The Netherlands.

Stolk EA, de Bont A, van Halteren AR, Bijlmer RJ, Poley MJ.

Expert Rev Pharmacoecon Outcomes Res. 2009 Feb;9(1):85-94. doi: 10.1586/14737167.9.1.85. Review.

PMID:
19371181
15.

Diffusion and use of health technology assessment in policy making: what lessons for decentralised healthcare systems?

Ciani O, Tarricone R, Torbica A.

Health Policy. 2012 Dec;108(2-3):194-202. doi: 10.1016/j.healthpol.2012.09.017.

PMID:
23093020
16.

Health technology assessment and primary data collection for reducing uncertainty in decision making.

Goeree R, Levin L, Chandra K, Bowen JM, Blackhouse G, Tarride JE, Burke N, Bischof M, Xie F, O'Reilly D.

J Am Coll Radiol. 2009 May;6(5):332-42. doi: 10.1016/j.jacr.2009.01.012.

PMID:
19394574
17.

International comparison of comparative effectiveness research in five jurisdictions: insights for the US.

Levy AR, Mitton C, Johnston KM, Harrigan B, Briggs AH.

Pharmacoeconomics. 2010;28(10):813-30. doi: 10.2165/11536150-000000000-00000. Review.

PMID:
20831289
18.
19.

Framework for describing and classifying decision-making systems using technology assessment to determine the reimbursement of health technologies (fourth hurdle systems).

Hutton J, McGrath C, Frybourg JM, Tremblay M, Bramley-Harker E, Henshall C.

Int J Technol Assess Health Care. 2006 Winter;22(1):10-8. Review.

PMID:
16673675
20.

Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis (MCDA): applying the EVIDEM framework to medicines appraisal.

Goetghebeur MM, Wagner M, Khoury H, Levitt RJ, Erickson LJ, Rindress D.

Med Decis Making. 2012 Mar-Apr;32(2):376-88. doi: 10.1177/0272989X11416870.

PMID:
21987539
Items per page

Supplemental Content

Support Center